Our metabolic screening also showed that U90926 deficiency does not impact other major plasma biomarkers of obesity, such as fibroblast growth factor 21 (FGF21), leptin, and insulin (Figure 3g–i). This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.